Simtriyo was just approved by the U.S. Food and Drug Administration to treat attention-deficit/hyperactivity disorder (ADHD) in children, teens, and adults. The ADHD ...

MannKind announced the FDA approved an at-home furosemide self-injection for treatment of edema in adults with HF or chronic ...

Joseph Mikhael, MD, MEd, discusses the potential and limitations of at-home cancer care using on-body injection technology.

Transformative delivery option that may support earlier management of worsening fluid overload with a self-administered option designed for use ...

A woman who reported alleged sexual abuse to Queensland Police says it was "retraumatising" to learn the investigation would not proceed because she had undergone eye movement desensitisation and ...

NEW YORK, June 01, 2026 (GLOBE NEWSWIRE) -- The idea of self-administered EMDR has gone from fringe curiosity to mainstream conversation remarkably quickly. Tools like Open EMDR have made bilateral ...

The U.S. Food & Drug Administration (FDA) has granted approval for subcutaneous administration of anifrolumab (SAPHNELO) for treatment of people living with moderately to severely active ...

CHICAGO — Gefurulimab, an investigational C5 inhibitor, delivered rapid and sustained clinical benefit in patients with generalized myasthenia gravis (gMG) compared to a placebo, new data show. The ...

To recover from abuse or another traumatic experience, some people turn to a therapy called eye-movement desensitisation and reprocessing, or EMDR. But this may present problems if these people pursue ...

Update: Self-administered Saphnelo remains under FDA review in the U.S. The U.S. Food and Drug Administration (FDA) issued a complete response letter requesting additional information from AstraZeneca ...

Credit: Milestone Pharmaceuticals. Each nasal spray device delivers 2 sprays containing a total of etripamil 70mg. The intranasal therapy consists of a novel calcium channel blocker and is designed to ...